expert roundtables

Optimizing the Approach to Early-Stage HER2+ Breast Cancer
Oncology

Optimizing the Approach to Early-Stage HER2+ Breast Cancer

expert roundtables
By Ian Krop, MD, PhD; Joseph A. Sparano, MD, FACP; Sara M. Tolaney, MD, MPH
Neuroendocrine Tumors and Carcinoid Syndrome: Individualizing Treatment to Match the Tumor Burden and Symptoms
Oncology

Neuroendocrine Tumors and Carcinoid Syndrome: Individualizing Treatment to Match the Tumor Burden and Symptoms

expert roundtables
By Jennifer R. Eads, MD; Jonathan R. Strosberg, MD; Thorvadur R. Halfdanarson, MD
The Spectrum of Complement-Driven Glomerulopathies
Nephrology

The Spectrum of Complement-Driven Glomerulopathies

expert roundtables
By Carla M. Nester, MD, MSA, FASN; Jai Radhakrishnan, MD, MS; Richard Lafayette, MD, FACP
High-Risk Chronic Lymphocytic Leukemia: Insights and Approaches
Oncology

High-Risk Chronic Lymphocytic Leukemia: Insights and Approaches

expert roundtables
By Jennifer R. Brown, MD, PhD; John C. Byrd, MD
Individualizing Initial Therapy for Chronic Lymphocytic Leukemia
Oncology

Individualizing Initial Therapy for Chronic Lymphocytic Leukemia

expert roundtables
By Jennifer R. Brown, MD, PhD; John C. Byrd, MD
Load More